Given geopolitical volatility and macroeconomic uncertainty, D-Wave Quantum stock looks like a very risky buy right now. With a market capitalization of roughly $9.5
Stock Market Live January 21, 2026: S&P 500 (SPY) Still Sinking on Tariff Concerns
Live Updates Get The Best SPDR S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on SPDR
Stock market today: Dow, S&P 500, Nasdaq jump after brutal sell-off as Trump rules out force on Greenland
US stocks turned higher on Wednesday in the wake of the steepest selloff in months as Wall Street took in President Trump’s speech at
NASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Still Look Soft in Early Wednesday Trading
Dow Jones 30 Technical Analysis The Dow Jones 30 is approaching the 50-day EMA, which, of course, is an indicator that’s fairly reliable, but
Warren Buffett's successor eyes selling off Berkshire Hathaway's 325 million Kraft Heinz shares
OMAHA, Neb. — OMAHA, Neb. (AP) — Warren Buffett’s successor appears to be considering his first significant move after taking over as CEO this
Supreme Court to hear arguments on Trump’s attempt to fire Lisa Cook from the Federal Reserve
Lisa Cook’s legal woes began last summer when President Donald Trump and his allies accused her of mortgage fraud involving a pair of properties
Social Security to send out benefits on Wednesday, Jan. 21: here’s who’s getting paid tomorrow
Millions of Social Security recipients in the U.S. are today set to get their first benefits of the new year, in the latest payment
3 Third Avenue Mutual Funds to Buy for Long-Term Returns
Third Avenue Management was founded in 1986 and is based in New York City. The company uses a systematic investment approach, which makes asset
Nvidia (NASDAQ: NVDA) Stock Price Prediction for 2026: Where Will It Be in 1 Year (Jan 21)
Shares of Nvidia Corp. (NASDAQ: NVDA) are 4.1% lower than a week ago. CEO Jensen Huang is reportedly planning a trip to China, and
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)
Among all the weight loss drugs, Ozempic has become a phenomenon. With as much as $17 billion in sales in 2024 and up to